Law
UPC rejects injunction against Celltrion omalizumab biosimilar
Novartis and Genentech have had their request for an injunction against biosimilar manufacturer Celltrion rejected after the Düsseldorf local division (LD) of the Unified Patent Court (UPC) considered there would be no imminent infringement of its pa